Apitegromab for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 May 2024: Trial started, NCT06445075
  2. 6 Jun 2024: Trial registered, NCT06445075

The trials

NCT06445075: Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

State
Completed
Phase
Phase 2
People
102 taking part
Started
21 May 2024
Primary completion
4 Mar 2025
Arms
Cohort 1
Results
None posted
Papers
doi:10.1038/s41591-026-04440-4
  1. 21 May 2024: Trial started
  2. 6 Jun 2024: Trial registered
  3. 17 Jun 2025: Trial completed

How the status changed

  1. 16 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.